Skip to content

Clinical trials

Phase 3 Diabetes Mellitus trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetes Mellitus Phase: Phase 3 Country / region: Germany Clear all

131 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20014
20023
20039
20046
20053
200613
20076
20086
200911
20108
20119
20128
20138
20147
20151
20166
20176
20183
20191
20202
20211
20222
20232
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed110
Terminated14
Unknown status3
Active, not recruiting2
Recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novo Nordisk A/S54
AstraZeneca15
Takeda11
Eli Lilly and Company7
Pfizer5
Allergan3
GlaxoSmithKline3
University of Erlangen-Nürnberg Medical School3
Apurano Pharmaceuticals GmbH2
Bayer2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetes Mellitus131
Diabetes Mellitus, Type 280
Diabetes Mellitus, Type 125
Glucose Metabolism Disorders14
Dyslipidemias8
Metabolic Diseases7
Cardiovascular Diseases6
Endocrine System Diseases5
Hypertension5
Obesity5

Trials

Showing 1 to 25 of 131. Each trial links to its page on Pharma Observatory.

31 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.